Cancer is no longer understood as a disease driven by isolated genetic mutations, but as a dynamic and adaptive biological system shaped by genomic instability, transcriptional reprogramming, proteomic signaling networks, metabolic rewiring, and microenvironmental interactions. Multi-Omics Integration in Cancer Therapeutics explores how the convergence of genomics, transcriptomics, proteomics, metabolomics, and epigenomics is transforming the landscape of oncology research and clinical care. This book provides a comprehensive framework for understanding how diverse molecular layers can be integrated to uncover causal disease mechanisms, identify actionable targets, and overcome therapeutic resistance. It highlights cutting-edge technologies including high-throughput sequencing, single-cell profiling, spatial transcriptomics, and artificial intelligence-driven analytics. Emphasis is placed on network biology approaches that reconstruct signaling circuits and predict drug responses within heterogeneous tumor ecosystems. Bridging molecular discovery with clinical translation, the text discusses biomarker development, molecular tumor boards, precision drug design, and systems-level strategies for personalized therapy. Through a synthesis of experimental evidence, computational modeling, and translational insights, this volume equips researchers, clinicians, and pharmaceutical scientists with the tools needed to harness integrative multi-omics for next-generation cancer therapeutics. Designed for advanced students, oncology researchers, and professionals in pharmaceutical and biomedical sciences, this book presents a forward-looking vision of precision oncology where data integration drives durable and individualized cancer treatment strategies.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Paperback. Etat : new. Paperback. Cancer is no longer understood as a disease driven by isolated genetic mutations, but as a dynamic and adaptive biological system shaped by genomic instability, transcriptional reprogramming, proteomic signaling networks, metabolic rewiring, and microenvironmental interactions. Multi-Omics Integration in Cancer Therapeutics explores how the convergence of genomics, transcriptomics, proteomics, metabolomics, and epigenomics is transforming the landscape of oncology research and clinical care. This book provides a comprehensive framework for understanding how diverse molecular layers can be integrated to uncover causal disease mechanisms, identify actionable targets, and overcome therapeutic resistance. It highlights cutting-edge technologies including high-throughput sequencing, single-cell profiling, spatial transcriptomics, and artificial intelligence-driven analytics. Emphasis is placed on network biology approaches that reconstruct signaling circuits and predict drug responses within heterogeneous tumor ecosystems. Bridging molecular discovery with clinical translation, the text discusses biomarker development, molecular tumor boards, precision drug design, and systems-level strategies for personalized therapy. Through a synthesis of experimental evidence, computational modeling, and translational insights, this volume equips researchers, clinicians, and pharmaceutical scientists with the tools needed to harness integrative multi-omics for next-generation cancer therapeutics. Designed for advanced students, oncology researchers, and professionals in pharmaceutical and biomedical sciences, this book presents a forward-looking vision of precision oncology where data integration drives durable and individualized cancer treatment strategies. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9789999338677
Quantité disponible : 1 disponible(s)
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9789999338677
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9789999338677
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9789999338677
Quantité disponible : Plus de 20 disponibles
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 125 pages. 6.00x0.29x9.00 inches. In Stock. N° de réf. du vendeur x-9999338674
Quantité disponible : 2 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26406528055
Quantité disponible : 4 disponible(s)
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Paperback. Etat : new. Paperback. Cancer is no longer understood as a disease driven by isolated genetic mutations, but as a dynamic and adaptive biological system shaped by genomic instability, transcriptional reprogramming, proteomic signaling networks, metabolic rewiring, and microenvironmental interactions. Multi-Omics Integration in Cancer Therapeutics explores how the convergence of genomics, transcriptomics, proteomics, metabolomics, and epigenomics is transforming the landscape of oncology research and clinical care. This book provides a comprehensive framework for understanding how diverse molecular layers can be integrated to uncover causal disease mechanisms, identify actionable targets, and overcome therapeutic resistance. It highlights cutting-edge technologies including high-throughput sequencing, single-cell profiling, spatial transcriptomics, and artificial intelligence-driven analytics. Emphasis is placed on network biology approaches that reconstruct signaling circuits and predict drug responses within heterogeneous tumor ecosystems. Bridging molecular discovery with clinical translation, the text discusses biomarker development, molecular tumor boards, precision drug design, and systems-level strategies for personalized therapy. Through a synthesis of experimental evidence, computational modeling, and translational insights, this volume equips researchers, clinicians, and pharmaceutical scientists with the tools needed to harness integrative multi-omics for next-generation cancer therapeutics. Designed for advanced students, oncology researchers, and professionals in pharmaceutical and biomedical sciences, this book presents a forward-looking vision of precision oncology where data integration drives durable and individualized cancer treatment strategies. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9789999338677
Quantité disponible : 1 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 407674856
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18406528061
Quantité disponible : 4 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. Cancer is no longer understood as a disease driven by isolated genetic mutations, but as a dynamic and adaptive biological system shaped by genomic instability, transcriptional reprogramming, proteomic signaling networks, metabolic rewiring, and microenvironmental interactions. Multi-Omics Integration in Cancer Therapeutics explores how the convergence of genomics, transcriptomics, proteomics, metabolomics, and epigenomics is transforming the landscape of oncology research and clinical care. This book provides a comprehensive framework for understanding how diverse molecular layers can be integrated to uncover causal disease mechanisms, identify actionable targets, and overcome therapeutic resistance. It highlights cutting-edge technologies including high-throughput sequencing, single-cell profiling, spatial transcriptomics, and artificial intelligence-driven analytics. Emphasis is placed on network biology approaches that reconstruct signaling circuits and predict drug responses within heterogeneous tumor ecosystems. Bridging molecular discovery with clinical translation, the text discusses biomarker development, molecular tumor boards, precision drug design, and systems-level strategies for personalized therapy. Through a synthesis of experimental evidence, computational modeling, and translational insights, this volume equips researchers, clinicians, and pharmaceutical scientists with the tools needed to harness integrative multi-omics for next-generation cancer therapeutics. Designed for advanced students, oncology researchers, and professionals in pharmaceutical and biomedical sciences, this book presents a forward-looking vision of precision oncology where data integration drives durable and individualized cancer treatment strategies. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9789999338677
Quantité disponible : 1 disponible(s)